Search Results 1581-1590 of 17614 for treatment resistant depression
... treatments and personalize treatment options. Harnessing the ... Mayo Clinic discovery of breast cancer treatment resistance can lead to new hope for some ...
... Treat Subjects with Relapsed or Refractory Multiple Myeloma and ... therapy, but this study will administer treatment in approximately 3 weeks.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
New study in Brain Communications finds personalized deep brain stimulation shows promise for drug-resistant · Hidden mutation leads to groundbreaking genetic ...
... refractory (R/R) MM. ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step ...
... treated with various forms of radiation therapy to improve the treatment of future patients. ... Platinum-resistant/refractory epithelial ovarian, primary ...
Participation eligibility · At least one prior therapy; · Refractory disease on most recent therapy, or disease recurrence following remission on most recent ...
The purpose of this study is to determine the safety and best dose of PRGN-3006 T Cells to treat relapsed/refractory Acute Myeloid Leukemia and High Risk ...
Proton therapy, Radiation therapy for breast cancer, External beam radiation therapy ... Mayo Clinic discovery of breast cancer treatment resistance can lead to ...
Analyzing the genetic makeup of breast cancer cells to understand how DNA changes affect response to cancer treatments and personalize treatment options.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.